Anssi Lipponen
Impact in
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
-
- S100 Proteins and Annexins 5
- Mitochondrial Function and Pathology 3
-
- SARS-CoV-2 detection and testing 8
- Viral gastroenteritis research and epidemiology 3
- SARS-CoV-2 and COVID-19 Research 3
- Co-authors
- Asla Pitkänen (15 shared papers)Noora Puhakka (10 shared papers)Jussi Paananen (3 shared papers)Tarja Pitkänen (11 shared papers)Ananda Tiwari (7 shared papers)Shalini Das Gupta (3 shared papers)K. Lehto (8 shared papers)Sami Oikarinen (7 shared papers)
In The Last Decade
Anssi Lipponen
27 papers receiving 535 citations
Peers
Comparison fields: 5 of 97
- Applied Microbiology and Biotechnology 23
- Molecular Medicine 40
- Infectious Diseases 138
- Cancer Research 95
- Endocrinology 25
Countries citing papers authored by Anssi Lipponen
This map shows the geographic impact of Anssi Lipponen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anssi Lipponen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anssi Lipponen more than expected).
Fields of papers citing papers by Anssi Lipponen
This network shows the impact of papers produced by Anssi Lipponen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anssi Lipponen. The network helps show where Anssi Lipponen may publish in the future.
Co-authors
The 25 scholars most cited alongside Anssi Lipponen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 94 | |
| 2 | 2022 | 84 | |
| 3 | 2016 | 55 | |
| 4 | 2022 | 55 | |
| 5 | 2016 | 33 | |
| 6 | 2018 | 29 | |
| 7 | 2023 | 23 | |
| 8 | 2019 | 23 | |
| 9 | 2024 | 19 | |
| 10 | 2014 | 15 | |
| 11 | 2018 | 14 | |
| 12 | 2024 | 12 | |
| 13 | 2019 | 11 | |
| 14 | 2021 | 10 | |
| 15 | 2023 | 10 | |
| 16 | 2019 | 10 | |
| 17 | 2019 | 9 | |
| 18 | 2018 | 9 | |
| 19 | 2020 | 5 | |
| 20 | 2021 | 4 |
About Anssi Lipponen
Anssi Lipponen is a scholar working on Molecular Biology, Infectious Diseases, Neurology, Cancer Research and Biomedical Engineering, having authored 29 papers that have together received 540 indexed citations. Recurring topics across this work include SARS-CoV-2 detection and testing (8 papers), Traumatic Brain Injury and Neurovascular Disturbances (7 papers), S100 Proteins and Annexins (5 papers), Biosensors and Analytical Detection (5 papers), Anesthesia and Neurotoxicity Research (4 papers), Viral gastroenteritis research and epidemiology (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Mitochondrial Function and Pathology (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (23 citations), Molecular Medicine (40 citations), Infectious Diseases (138 citations), Cancer Research (95 citations) and Endocrinology (25 citations). Anssi Lipponen has collaborated with scholars based in Finland, Australia and Nigeria. Frequent co-authors include Asla Pitkänen, Noora Puhakka, Jussi Paananen, Tarja Pitkänen, Ananda Tiwari, Shalini Das Gupta, K. Lehto, Sami Oikarinen, Kirsi Rilla and Arto Koistinen. Their work appears in journals such as International Journal of Molecular Sciences, Scientific Reports, Frontiers in Microbiology, Water Research and One Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.